DHR
Danaher Corporation insider trading
Health Care · Heavy selling
Close · Oct 5, 2026
$221.21
+5.3% over 12 months
Share price and insider trades
DHR closeInsider buyInsider sale
Bought, 12 months$0
Sold, 12 months$258M
Insiders buying0
Insiders selling8
Valuation, profit and volume
P/E (trailing)n/aSector median 24.5
Market value—
Profit margin—Revenue growth —
Volume vs. 50-day0.9×Last 5 sessions
Insiders' paper profit—On all tracked purchases —
Summary
Over the past 12 months, 0 Danaher Corporation insiders reported open-market purchases totaling $0, while 8 insiders reported sales totaling $258M. 0 of 20 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales. 69 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 24SEC | Rainer BlairCEO, President | Sell | 39,193 | $218.73 | $8.6M | +1.1% | — |
| Aug 24SEC | Rainer BlairCEO, President | Sell | 11,307 | $217.77 | $2.5M | +1.6% | — |
| Aug 24SEC | Rainer BlairCEO, President | Sell | 7,755 | $219.35 | $1.7M | +0.8% | — |
| May 4SEC | Alan G SpoonDirector | Sell | 1,358 | $174.67 | $237K | +26.6% | — |
| Feb 20SEC | Gregory M MilosevichPresident | Sell | 1,320 | $208.01 | $275K | +6.3% | — |
| Nov 26SEC | Mitchell P RalesChair | Sell | 35,899 | $230.27 | $8.3M | -3.9% | — |
| Nov 26SEC | Mitchell P RalesChair | Sell | 4,726 | $231.19 | $1.1M | -4.3% | — |
| Nov 19SEC | Teri ListDirector | Sell | 3,298 | $226.50 | $747K | -2.3% | — |
| Nov 13SEC | Mitchell P RalesChair | Sell | 254,553 | $218.27 | $55.6M | +1.3% | — |
| Nov 13SEC | Mitchell P RalesChair | Sell | 133,233 | $219.43 | $29.2M | +0.8% | — |
| Nov 13SEC | Mitchell P RalesChair | Sell | 25,855 | $217.64 | $5.6M | +1.6% | — |
| Nov 13SEC | Mitchell P RalesChair | Sell | 23,359 | $220.15 | $5.1M | +0.5% | — |
| Nov 13SEC | Matthew McgrewCFO | Sell | 16,172 | $214.62 | $3.5M | +3.1% | — |
| Nov 13SEC | Brian W EllisPresident | Sell | 14,667 | $219.23 | $3.2M | +0.9% | — |
| Nov 13SEC | Brian W EllisPresident | Sell | 7,109 | $219.21 | $1.6M | +0.9% | — |
| Nov 12SEC | Georgeann CoucharaSvp, Human Resources | Sell | 4,176 | $210.44 | $879K | +5.1% | — |
| Nov 12SEC | Georgeann CoucharaSvp, Human Resources | Sell | 998 | $210.31 | $210K | +5.2% | — |
| Nov 4SEC | Mitchell P RalesChair | Sell | 308,423 | $215.67 | $66.5M | +2.6% | — |
| Nov 4SEC | Mitchell P RalesChair | Sell | 223,449 | $216.26 | $48.3M | +2.3% | — |
| Nov 4SEC | Mitchell P RalesChair | Sell | 68,128 | $217.17 | $14.8M | +1.9% | — |
Insiders at Danaher Corporation
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Mitchell P RalesChair | — | $235M | Aug 6, 2026 | — |
| Rainer BlairCEO, President | — | $12.7M | Aug 24, 2026 | — |
| Brian W EllisPresident | — | $4.8M | Feb 6, 2026 | — |
| Matthew McgrewPresident | — | $3.5M | Mar 3, 2026 | — |
| Georgeann CoucharaSvp, Human Resources | — | $1.1M | May 19, 2026 | — |
| Teri ListDirector | — | $747K | May 19, 2026 | — |
| Gregory M MilosevichPresident | — | $275K | Aug 6, 2026 | — |
| Alan G SpoonDirector | — | $237K | May 19, 2026 | — |
| Jose-carlos Gutierrez-ramosSvp, Chief Science Officer | — | — | Aug 6, 2026 | — |
| Christopher Paul RileyPresident | — | — | Aug 6, 2026 | — |
| Steven M RalesChair | — | — | Aug 6, 2026 | — |
| Elias A. ZerhouniDirector | — | — | Jul 16, 2026 | — |
| Linda FillerDirector | — | — | Jul 16, 2026 | — |
| Christopher BoudaVp, Chief Accounting Officer | — | — | Jul 16, 2026 | — |
| Charles W LamannaDirector | — | — | May 19, 2026 | — |
| Feroz DewanDirector | — | — | May 19, 2026 | — |
| A Shane SandersDirector | — | — | May 19, 2026 | — |
| Raymond C StevensDirector | — | — | May 19, 2026 | — |
| Montgomery Julie A SawyerPresident | — | — | Mar 3, 2026 | — |
| Matthew E GuginoCFO | — | — | Mar 3, 2026 | — |
| R Bradley GraySvp Strategic Development | — | — | Mar 3, 2026 | — |
| Jonathan LeikenGeneral Counsel | — | — | Mar 3, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
Common questions about DHR insiders
Are Danaher Corporation insiders buying DHR stock?
In the past 12 months, 0 insiders reported open-market purchases of DHR worth $0.
Are Danaher Corporation insiders selling DHR stock?
8 insiders reported sales worth $258M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.